|
![]() |
|||
|
||||
OverviewVaccines for lung cancer represent a revolutionary development in oncology that has the potential to fundamentally change the way we treat this deadly disease. Traditionally, lung cancer has been fought with methods such as surgery, chemotherapy and radiotherapy. These approaches focus primarily on the direct removal or destruction of tumor cells. Vaccines, on the other hand, offer a new, immunological approach by stimulating the body's own immune system to specifically recognize and destroy cancer cells. There are two main approaches in the development of vaccines against lung cancer: prophylactic and therapeutic vaccines. Prophylactic vaccines aim to prevent cancer before it develops by sensitizing the immune system to potential tumor cells. Therapeutic vaccines, on the other hand, are aimed at patients who have already been diagnosed with lung cancer and are designed to strengthen the immune system in order to fight the existing cancer. Research in this field is progressing rapidly, supported by advances in genomics, immunology and personalized medicine. Clinical trials have already shown promising results, especially in combination with other immunotherapies, raising hopes that vaccines could play a crucial role in the treatment of lung cancer in the future. Full Product DetailsAuthor: Jenna Bridgerton , Francis ConnorPublisher: Bremen University Press Imprint: Bremen University Press Dimensions: Width: 14.00cm , Height: 0.70cm , Length: 21.60cm Weight: 0.159kg ISBN: 9783689047597ISBN 10: 3689047595 Pages: 118 Publication Date: 26 August 2024 Audience: General/trade , General Format: Paperback Publisher's Status: Active Availability: In Print ![]() This item will be ordered in for you from one of our suppliers. Upon receipt, we will promptly dispatch it out to you. For in store availability, please contact us. Table of ContentsReviewsAuthor InformationTab Content 6Author Website:Countries AvailableAll regions |